Browse Drug Recalls
837 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 837 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 837 FDA drug recalls in NC.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 7, 2023 | Clopidogrel Tablets USP, 75 mg, Rx Only, Packaged in a) 30-count bottles NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Phenylephrine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), Rx Only, 5 ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Vigabatrin for Oral Solution, USP, 500 mg, Rx Only, 50-packets/carton, Manufa... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Dofetilide Capsules, 125 mcg (0.125 mg), 60-count bottle, Rx only, Manufactur... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Dofetilide Capsules 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 20 mg Rx Only, packaged as, a) 30-count bottle, ND... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP 15 mg, Rx Only, 100-count bottle, Manufac... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Rosuvastatin Tablets, USP, 5 mg*, Rx Only, Packaged as: a) 90-count bottle, ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Rosuvastatin Tablets, USP, 10 mg*, Rx Only, Packaged as: a) 90-count bottle,... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glimepiride Tablets USP, 2 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glycopyrrolate Injection, USP, 0.4 mg/2 mL (0.2 mg/mL) 2 mL Single Dose Vial ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 2 mg, Rx Only, Packaged as a) 30-count bottle, NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Atorvastatin Calcium Tablets USP 20 mg* Rx Only, Packaged as a) 90 Tablets N... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Rosuvastatin Tablets, USP 40 mg* Rx Only, Packaged as: a) 30-count bottle NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Doxazosin Tablets USP, 2 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Tadalafil Tablets, USP, 20 mg, Rx Only, Packaged as: a) 30-count bottle NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets, USP, 10 mg, Rx Only, Packaged as: a) 90-count bottle NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets USP 80 mg Rx Only, Packaged as: a) 90-count bottle NDC 16... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets USP 5 mg Rx Only, Packaged as: a) 90-count bottle NDC 167... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 20 mL Multiple Dose Vial... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Daptomycin for Injection 350 mg/vial, Rx only, Packaged as: a) Single-dose vi... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufact... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Phenylephrine Hydrochloride Injection, USP 100 mg/10 mL (10 mg/mL), Rx Only, ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets USP 20 mg Rx Only, Packaged as: a) 90-count bottle NDC 16... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 1 mg*, 100-count bottle, Rx Only, Manufactured for: Ac... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 10 mL Multi... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pirfenidone Tablets 801 mg, Rx Only, 90-count bottle, Manufactured for: Accor... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP 7.5 mg, 100-count bottle, Rx Only, Manufa... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 3 mg*, 100-count bottle, Rx Only, Manufactured for: Ac... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 5 mg* 100-count bottle, Rx Only, Manufactured for: Acc... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufac... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 2 mg*, 100-count bottle, Rx Only, Manufactured for: A... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Phenylephrine Hydrochloride Injection, USP 10 mg/mL Rx Only, 1 mL Single Dose... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Rosuvastatin Tablets, USP 20 mg* Rx Only, Packaged as: a) 90-count bottle ND... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Doxazosin Tablets USP 1 mg, Rx Only, Packaged as: a) 100-count bottle NDC 167... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Doxazosin Tablets USP, 8 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-4... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pravastatin Sodium Tablets USP, 40 mg, Rx Only, 1,000-count bottle Manufactur... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Tadalafil Tablets, USP, 2.5 mg Rx Only, Packaged as: a) 30-count bottle NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Finasteride Tablets USP 1 mg, 90-count bottle, Keeps, Rx Only, Manufactured f... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Simvastatin Tablets USP 40 mg Rx Only, Packaged as: a) 90-count tablets NDC 1... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 15 mg Rx Only, Packaged as: a) 30-count bottle NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glimepiride Tablets USP, 1 mg, Rx Only, Packaged in: a) 100-count bottle NDC... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Aripiprazole Tablets, USP 10 mg Rx Only, Packaged as a) 30-count bottle, NDC ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Tadalafil Tablets, USP 10 mg Rx Only, Packaged as: a) 30-count bottle NDC 1... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 5 mL Multiple Dose Vial, ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pravastatin Sodium Tablets USP, 80 mg, Rx Only, 90- count bottle, Manufacture... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Atorvastatin Calcium Tablets USP, 10 mg* Rx Only, Packaged as a) 90 Tablets ... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | BusPIRone Hydrochloride Tablets USP, 5 mg, Rx Only, Packaged as: a) 100 Table... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | rOPINIRole Tablets USP 0.25 mg*, 100-count bottle, Rx Only, Manufactured for:... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
| Feb 7, 2023 | Pirfenidone Tablets 267 mg 90-count bottle x3/Carton, Rx Only, Manufactured f... | CGMP Deviations: recalling drug products following an FDA inspection. | Class II | Accord Healthcare, Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.